{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:16:25Z","timestamp":1791155785274,"version":"4.1.0"},"reference-count":147,"publisher":"National Institute for Health and Care Research","issue":"34","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/96\/01"],"award-info":[{"award-number":["10\/96\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title><jats:p>Drug-resistant tuberculosis (TB), especially multidrug-resistant (MDR, resistance to rifampicin and isoniazid) disease, is associated with a worse patient outcome. Drug resistance diagnosed using microbiological culture takes days to weeks, as TB bacteria grow slowly. Rapid molecular tests for drug resistance detection (1 day) are commercially available and may promote faster initiation of appropriate treatment.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-2\"><jats:title>Objectives<\/jats:title><jats:p>To (1) conduct a systematic review of evidence regarding diagnostic accuracy of molecular genetic tests for drug resistance, (2) conduct a health-economic evaluation of screening and diagnostic strategies, including comparison of alternative models of service provision and assessment of the value of targeting rapid testing at high-risk subgroups, and (3) construct a transmission-dynamic mathematical model that translates the estimates of diagnostic accuracy into estimates of clinical impact.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-3\"><jats:title>Review methods and data sources<\/jats:title><jats:p>A standardised search strategy identified relevant studies from EMBASE, PubMed, MEDLINE, Bioscience Information Service (BIOSIS), System for Information on Grey Literature in Europe Social Policy &amp; Practice (SIGLE) and Web of Science, published between 1 January 2000 and 15 August 2013. Additional \u2018grey\u2019 sources were included. Quality was assessed using quality assessment of diagnostic accuracy studies version 2 (QUADAS-2). For each diagnostic strategy and population subgroup, a care pathway was constructed to specify which medical treatments and health services that individuals would receive from presentation to the point where they either did or did not complete TB treatment successfully. A total cost was estimated from a health service perspective for each care pathway, and the health impact was estimated in terms of the mean discounted quality-adjusted life-years (QALYs) lost as a result of disease and treatment. Costs and QALYs were both discounted at 3.5% per year. An integrated transmission-dynamic and economic model was used to evaluate the cost-effectiveness of introducing rapid molecular testing (in addition to culture and drug sensitivity testing). Probabilistic sensitivity analysis was performed to evaluate the impact on cost-effectiveness of diagnostic and treatment time delays, diagnosis and treatment costs, and associated QALYs.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-4\"><jats:title>Results<\/jats:title><jats:p>A total of 8922 titles and abstracts were identified, with 557 papers being potentially eligible. Of these, 56 studies contained sufficient test information for analysis. All three commercial tests performed well when detecting drug resistance in clinical samples, although with evidence of heterogeneity between studies. Pooled sensitivity for GenoType<jats:sup>\u00ae<\/jats:sup>MTBDRplus (Hain Lifescience, Nehren, Germany) (isoniazid and rifampicin resistance), INNO-LiPA Rif.TB<jats:sup>\u00ae<\/jats:sup>(Fujirebio Europe, Ghent, Belgium) (rifampicin resistance) and Xpert<jats:sup>\u00ae<\/jats:sup>MTB\/RIF (Cepheid Inc., Sunnyvale, CA, USA) (rifampicin resistance) was 83.4%, 94.6%, 95.4% and 96.8%, respectively; equivalent pooled specificity was 99.6%, 98.2%, 99.7% and 98.4%, respectively. Results of the transmission model suggest that all of the rapid assays considered here, if added to the current diagnostic pathway, would be cost-saving and achieve a reduction in expected QALY loss compared with current practice. GenoType MTBDRplus appeared to be the most cost-effective of the rapid tests in the South Asian population, although results were similar for GeneXpert. In all other scenarios GeneXpert appeared to be the most cost-effective strategy.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-5\"><jats:title>Conclusions<\/jats:title><jats:p>Rapid molecular tests for rifampicin and isoniazid resistance were sensitive and specific. They may also be cost-effective when added to culture drug susceptibility testing in the UK. There is global interest in point-of-care testing and further work is needed to review the performance of emerging tests and the wider health-economic impact of decentralised testing in clinics and primary care, as well as non-health-care settings, such as shelters and prisons.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-6\"><jats:title>Study registration<\/jats:title><jats:p>This study is registered as PROSPERO CRD42011001537.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-7\"><jats:title>Funding<\/jats:title><jats:p>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta19340","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T09:10:16Z","timestamp":1431335416000},"page":"1-188","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":69,"title":["Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis"],"prefix":"10.3310","volume":"19","author":[{"given":"Francis","family":"Drobniewski","sequence":"first","affiliation":[{"name":"Public Health England National Mycobacterium Reference Laboratory, London, UK"},{"name":"Departments of Microbiology and Respiratory Medicine, Barts Health NHS Trust, London, UK"},{"name":"Department of Infectious Diseases and Immunity, Imperial College London, London, UK"},{"name":"Centre of Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cooke","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Epidemiology, Research Department of Infection and Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Jordan","sequence":"additional","affiliation":[{"name":"Health Economics Research Group, Brunel University, Uxbridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Casali","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Immunity, Imperial College London, London, UK"},{"name":"Centre of Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendai","family":"Mugwagwa","sequence":"additional","affiliation":[{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"},{"name":"Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Broda","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Immunity, Imperial College London, London, UK"},{"name":"Centre of Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Townsend","sequence":"additional","affiliation":[{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Sivaramakrishnan","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Green","sequence":"additional","affiliation":[{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"},{"name":"Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lipman","sequence":"additional","affiliation":[{"name":"Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lord","sequence":"additional","affiliation":[{"name":"Health Economics Research Group, Brunel University, Uxbridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"White","sequence":"additional","affiliation":[{"name":"Modelling and Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK"},{"name":"Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK"},{"name":"National Institute for Health Research (NIHR) Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Epidemiology, Research Department of Infection and Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2015,5]]},"reference":[{"key":"key20150508101526144_ref1-bib1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/rccm.200801-132OC","article-title":"Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis","volume":"178","author":"Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key20150508101526144_ref1-bib2","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1001\/jama.300.18.2153","article-title":"Extensively drug-resistant tuberculosis in the United States, 1993\u20132007","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"key":"key20150508101526144_ref1-bib3","doi-asserted-by":"publisher","first-page":"e20531","DOI":"10.1371\/journal.pone.0020531","article-title":"Survival of civilian and prisoner drug-sensitive, multi- and extensive drug-resistant tuberculosis cohorts prospectively followed in Russia","volume":"6","author":"Balabanova","year":"2011","journal-title":"PLOS ONE"},{"key":"key20150508101526144_ref1-bib4","doi-asserted-by":"publisher","first-page":"e000351","DOI":"10.1136\/bmjopen-2011-000351","article-title":"Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study","volume":"1","author":"Balabanova","year":"2011","journal-title":"BMJ Open"},{"key":"key20150508101526144_ref1-bib5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1126\/science.319.5865.894","article-title":"Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination","volume":"319","author":"Koenig","year":"2008","journal-title":"Science"},{"key":"key20150508101526144_ref1-bib6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"key20150508101526144_ref1-bib7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/thoraxjnl-2012-201663","article-title":"MDR, XDR, TDR tuberculosis: ominous progression","volume":"67","author":"Udwadia","year":"2012","journal-title":"Thorax"},{"key":"key20150508101526144_ref1-bib8","volume-title":"Global Tuberculosis Report 2013","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib9","volume-title":"Tuberculosis Surveillance and Monitoring In Europe","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib10","volume-title":"Prevention and Control Of Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis","author":"","year":"2009"},{"key":"key20150508101526144_ref1-bib11","volume-title":"Tuberculosis in the UK","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0195-6701(98)90324-3","article-title":"An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital","volume":"39","author":"Breathnach","year":"1998","journal-title":"J Hosp Infect"},{"key":"key20150508101526144_ref1-bib13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/thx.2003.010405","article-title":"Outbreak of isoniazid resistant tuberculosis in north London","volume":"59","author":"Ruddy","year":"2004","journal-title":"Thorax"},{"key":"key20150508101526144_ref1-bib14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0140-6736(93)90417-F","article-title":"Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis","volume":"341","author":"Telenti","year":"1993","journal-title":"Lancet"},{"key":"key20150508101526144_ref1-bib15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"key20150508101526144_ref1-bib16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"key20150508101526144_ref1-bib17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1473-3099(03)00544-9","article-title":"Modern laboratory diagnosis of tuberculosis","volume":"3","author":"Drobniewski","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"key20150508101526144_ref1-bib18","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"Sandgren","year":"2009","journal-title":"PLOS Med"},{"key":"key20150508101526144_ref1-bib19","first-page":"565","article-title":"Mycobacteria: laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti","year":"1963","journal-title":"Bull World Health Organ"},{"key":"key20150508101526144_ref1-bib20","volume-title":"MGIT Procedure Manual","author":"Siddiqi","year":"2006"},{"key":"key20150508101526144_ref1-bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JCM.37.3.748-752.1999","article-title":"Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria","volume":"37","author":"Hanna","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5588\/ijtld.10.0065","article-title":"Microcolony culture techniques for tuberculosis diagnosis: a systematic review","volume":"16","author":"Leung","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa055524","article-title":"Microscopic-observation drug-susceptibility assay for the diagnosis of TB","volume":"355","author":"Moore","year":"2006","journal-title":"N Engl J Med"},{"key":"key20150508101526144_ref1-bib24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.5588\/ijtld.11.0609","article-title":"The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains","volume":"16","author":"Toit","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights","volume":"8","author":"Musser","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"key20150508101526144_ref1-bib26","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazb\u00f3n","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key20150508101526144_ref1-bib27","doi-asserted-by":"publisher","first-page":"e1536","DOI":"10.1371\/journal.pone.0001536","article-title":"Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression","volume":"3","author":"Ling","year":"2008","journal-title":"PLOS ONE"},{"key":"key20150508101526144_ref1-bib28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/jac\/dkp124","article-title":"Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis","volume":"63","author":"Pietzka","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key20150508101526144_ref1-bib29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"key20150508101526144_ref1-bib30","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1128\/JCM.00824-10","article-title":"Loop-mediated isothermal amplification for rapid and reliable diagnosis of tuberculous meningitis","volume":"49","author":"Nagdev","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib31","volume-title":"Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis","author":"","year":"2008"},{"key":"key20150508101526144_ref1-bib32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2334-5-62","article-title":"A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis","volume":"5","author":"Morgan","year":"2005","journal-title":"BMC Infect Dis"},{"key":"key20150508101526144_ref1-bib33","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1128\/JCM.43.9.4880-4884.2005","article-title":"Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis","volume":"43","author":"Viveiros","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib34","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10096-011-1453-1","article-title":"Performance of the GenoType\u00ae MTBDRPlus assay in routine settings: a multicenter study","volume":"31","author":"Mironova","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key20150508101526144_ref1-bib35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/thoraxjnl-2011-200610","article-title":"Rapid molecular detection of tuberculosis and rifampicin drug resistance: retrospective analysis of a national UK molecular service over the last decade","volume":"67","author":"Seoudi","year":"2012","journal-title":"Thorax"},{"key":"key20150508101526144_ref1-bib36","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1128\/JCM.00039-12","article-title":"Detection of resistance to second-line antituberculosis drugs by use of the GenoType MTBDRsl assay: a multicenter evaluation and feasibility study","volume":"50","author":"Ignatyeva","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/JCM.02513-12","article-title":"Diagnostic accuracy of the genotype MTBDRsl assay for rapid diagnosis of extensively drug-resistant tuberculosis in HIV-coinfected patients","volume":"51","author":"Kontsevaya","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib38","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"key":"key20150508101526144_ref1-bib39","volume-title":"Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF system","author":"","year":"2011"},{"key":"key20150508101526144_ref1-bib40","volume-title":"WHO Monitoring of Xpert MTB\/RIF Roll-Out","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib41","doi-asserted-by":"publisher","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"Vassall","year":"2011","journal-title":"PLOS Med"},{"key":"key20150508101526144_ref1-bib42","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/ng.2743","article-title":"Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-D-arabinose biosynthetic and utilization pathway genes","volume":"45","author":"Safi","year":"2013","journal-title":"Nat Genet"},{"key":"key20150508101526144_ref1-bib43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ng.2735","article-title":"Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat Genet"},{"key":"key20150508101526144_ref1-bib44","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ng.2747","article-title":"Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis","volume":"45","author":"Farhat","year":"2013","journal-title":"Nat Genet"},{"key":"key20150508101526144_ref1-bib45","doi-asserted-by":"publisher","first-page":"CD009593","DOI":"10.1002\/14651858.CD009593.pub2","article-title":"Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults","volume":"1","author":"Steingart","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key20150508101526144_ref1-bib46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1183\/09031936.00061808","article-title":"GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis","volume":"32","author":"Ling","year":"2008","journal-title":"Eur Respir J"},{"key":"key20150508101526144_ref1-bib47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"key20150508101526144_ref1-bib48","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/sim.1185","article-title":"Exploring sources of heterogeneity in systematic reviews of diagnostic tests","volume":"21","author":"Lijmer","year":"2002","journal-title":"Stat Med"},{"key":"key20150508101526144_ref1-bib49","volume-title":"Evaluation Of Diagnostic Test From Accuracy To Outcome","author":"Lijmer","year":"2001"},{"key":"key20150508101526144_ref1-bib50","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/sim.1752","article-title":"Controlling the risk of spurious findings from meta-regression","volume":"23","author":"Higgins","year":"2004","journal-title":"Stat Med"},{"key":"key20150508101526144_ref1-bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0873-2159(15)30381-0","article-title":"Multi-drug resistant tuberculosis and the red queen: diagnosis speed is crucial","volume":"13","author":"Costeira","year":"2007","journal-title":"Rev Port Pneumol"},{"key":"key20150508101526144_ref1-bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1099\/0022-1317-49-3-271","article-title":"A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis","volume":"49","author":"Drobniewski","year":"2000","journal-title":"J Med Microbiol"},{"key":"key20150508101526144_ref1-bib53","first-page":"525","article-title":"Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by line probe assay (LiPA)","volume":"79","author":"Higuchi","year":"2004","journal-title":"Kekkaku"},{"key":"key20150508101526144_ref1-bib54","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1128\/JCM.41.9.4454-4456.2003","article-title":"Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay","volume":"41","author":"Johansen","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2334-9-139","article-title":"Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda","volume":"9","author":"Ogwang","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key20150508101526144_ref1-bib56","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3201\/eid1205.041339","article-title":"Mycobacterium tuberculosis and rifampin resistance","volume":"12","author":"Sam","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key20150508101526144_ref1-bib57","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3201\/eid1109.041236","article-title":"Multidrug-resistant tuberculosis detection, Latvia","volume":"11","author":"Skenders","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key20150508101526144_ref1-bib58","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.5588\/ijtld.11.0602","article-title":"The Xpert\u00ae MTB\/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden","volume":"16","author":"Kim","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib59","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10096-012-1798-0","article-title":"Performance of Cepheid\u00ae Xpert MTB\/RIF\u00ae and TB-Biochip\u00ae MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis","volume":"32","author":"Kurbatova","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key20150508101526144_ref1-bib60","first-page":"S604","article-title":"Evaluation of GeneXpertMTB\/RIF assay on pulmonary and extra-pulmonary samples in a high-throughput laboratory","volume":"16","author":"Naidoo","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key20150508101526144_ref1-bib61","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/cid\/cis631","article-title":"Evaluation of the Xpert MTB\/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic","volume":"55","author":"O\u2019Grady","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key20150508101526144_ref1-bib62","doi-asserted-by":"publisher","first-page":"e31563","DOI":"10.1371\/journal.pone.0031563","article-title":"Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis","volume":"7","author":"Tukvadze","year":"2012","journal-title":"PLOS ONE"},{"key":"key20150508101526144_ref1-bib63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5588\/ijtld.12.0197","article-title":"GenoType\u00ae MTBDR plus assay detection of drug-resistant tuberculosis in routine practice in Korea","volume":"17","author":"Lyu","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib64","first-page":"1057","article-title":"Application of the GenoType MTBDR assay directly on sputum specimens","volume":"10","author":"Hillemann","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib65","first-page":"767","article-title":"Original Article Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan","volume":"62","author":"Farooqi","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"key20150508101526144_ref1-bib66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijmyco.2013.04.002","article-title":"Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting","volume":"2","author":"Eliseev","year":"2013","journal-title":"Int J Mycobacteriol"},{"key":"key20150508101526144_ref1-bib67","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1128\/JCM.00745-11","article-title":"DNA extracted from stained sputum smears can be used in the MTBDRplus assay","volume":"49","author":"Dubois Cauwelaert","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib68","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1128\/JCM.05723-11","article-title":"GenoType MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa","volume":"50","author":"Dorman","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib69","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1128\/JCM.05903-11","article-title":"First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances","volume":"50","author":"Crudu","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib70","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1164\/rccm.200709-1436OC","article-title":"Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa","volume":"177","author":"Barnard","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key20150508101526144_ref1-bib71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1590\/S1726-46342012000100014","article-title":"Molecular test GenoType MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis","volume":"29","author":"Asencios","year":"2012","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"key20150508101526144_ref1-bib72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2334-10-123","article-title":"Validation of the GenoType\u00ae MTBDR plus assay for detection of MDR-TB in a public health laboratory in Thailand","volume":"10","author":"Anek-Vorapong","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key20150508101526144_ref1-bib73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2334-10-41","article-title":"Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda","volume":"10","author":"Albert","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key20150508101526144_ref1-bib74","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1128\/JCM.01506-06","article-title":"Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin","volume":"44","author":"Somoskovi","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib75","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1128\/JCM.00618-08","article-title":"GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples","volume":"46","author":"Lacoma","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib76","doi-asserted-by":"publisher","first-page":"e49433","DOI":"10.1371\/journal.pone.0049433","article-title":"Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments","volume":"7","author":"Ajbani","year":"2012","journal-title":"PLOS ONE"},{"key":"key20150508101526144_ref1-bib77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1128\/JCM.05274-11","article-title":"GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples","volume":"50","author":"Lacoma","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib78","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1128\/JCM.00081-09","article-title":"Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin\u2013capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens","volume":"47","author":"Hillemann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib79","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1183\/09031936.00164111","article-title":"GenoType MTBDRsl performance on clinical samples with diverse genetic background","volume":"40","author":"Miotto","year":"2012","journal-title":"Eur Respir J"},{"key":"key20150508101526144_ref1-bib80","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1164\/rccm.201205-0960OC","article-title":"GenoType MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory","volume":"186","author":"Barnard","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"key20150508101526144_ref1-bib81","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10517-008-0034-5","article-title":"Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips","volume":"145","author":"Antonova","year":"2008","journal-title":"Bull Exp Biol Med"},{"key":"key20150508101526144_ref1-bib82","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1157\/13092465","article-title":"Validaci\u00f3n de la reacci\u00f3n en cadena de la polimerasa basada en generador universal de heterod\u00faplex para la identificaci\u00f3n de Mycobacterium tuberculosis resistente a rifampicina y multirresistente en Lima, Per\u00fa","volume":"24","author":"Calder\u00f3n-Espinoza","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"key20150508101526144_ref1-bib83","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3343\/kjlm.2009.29.5.455","article-title":"Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea","volume":"29","author":"Cho","year":"2009","journal-title":"Korean J Lab Med"},{"key":"key20150508101526144_ref1-bib84","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1378\/chest.09-0150","article-title":"Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting","volume":"137","author":"Choi","year":"2010","journal-title":"Chest"},{"key":"key20150508101526144_ref1-bib85","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1128\/JCM.01239-11","article-title":"Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens","volume":"49","author":"Garc\u00eda-Sierra","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib86","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1469-0691.2005.01183.x","article-title":"Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis","volume":"11","author":"Gryadunov","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"key20150508101526144_ref1-bib87","first-page":"914","article-title":"Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system","volume":"13","author":"Guo","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib88","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1128\/JCM.03436-12","article-title":"Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis","volume":"51","author":"Pang","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib89","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1128\/JCM.39.7.2610-2617.2001","article-title":"Detection of rifampin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing","volume":"39","author":"Kim","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib90","doi-asserted-by":"publisher","first-page":"e52953","DOI":"10.1371\/journal.pone.0052953","article-title":"Evaluation of biochip system in determining isoniazid and rifampicin resistances of Mycobacterium tuberculosis in sputum samples","volume":"7","author":"Lu","year":"2012","journal-title":"PLOS ONE"},{"key":"key20150508101526144_ref1-bib91","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1128\/JCM.39.7.2531-2540.2001","article-title":"Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips","volume":"39","author":"Mikhailovich","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib92","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/AAC.47.7.2231-2235.2003","article-title":"Allele-specific rpoB PCR Assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears","volume":"47","author":"Mokrousov","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key20150508101526144_ref1-bib93","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1134\/S002689331301010X","article-title":"Comparative analysis of TB-Biochip, Xpert MTB\/RIF, and GenoType MTBDRplus test systems for rapid determination of mutations responsible for drug resistance of M. tuberculosis complex (in sputum from patients in Moscow region)","volume":"47","author":"Nosova","year":"2013","journal-title":"Mol Biol"},{"key":"key20150508101526144_ref1-bib94","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1128\/JCM.01594-08","article-title":"Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients","volume":"47","author":"Sheen","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib95","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.diagmicrobio.2010.08.021","article-title":"Direct detection of isoniazid-resistant Mycobacterium tuberculosis in respiratory specimens by multiplex allele-specific polymerase chain reaction","volume":"69","author":"Siu","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20150508101526144_ref1-bib96","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.tube.2012.01.004","article-title":"Multiplex allele specific PCR for rapid detection of extensively drug resistant tuberculosis","volume":"92","author":"Vadwai","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"key20150508101526144_ref1-bib97","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2334-12-303","article-title":"Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBioTM DNA microarray: a prospective validation study","volume":"12","author":"Zhang","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key20150508101526144_ref1-bib98","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S2173-5115(09)70118-6","article-title":"Multidrug-resistant tuberculosis: rapid molecular detection with MTBDRplus assay in clinical samples","volume":"XV","author":"Macedo","year":"2009","journal-title":"Rev Port Pneumol"},{"key":"key20150508101526144_ref1-bib99","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6890-9-2","article-title":"Performance of the GenoType MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation","volume":"9","author":"Nikolayevskyy","year":"2009","journal-title":"BMC Clin Pathol"},{"key":"key20150508101526144_ref1-bib100","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1128\/JCM.00364-13","article-title":"Performance of the GenoType MTBDRplus assay directly on sputum specimens from Brazilian patients with tuberculosis treatment failure or relapse","volume":"51","author":"Maschmann","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib101","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1128\/JCM.01889-10","article-title":"Evaluation of two molecular assays for rapid detection of Mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and multidrug-resistance settings","volume":"49","author":"Kontsevaya","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2010.01.009","article-title":"Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses","volume":"64","author":"Al Khalaf","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key20150508101526144_ref1-bib103","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/bmj.38793.637789.2F","article-title":"Sample sizes of studies on diagnostic accuracy: literature survey","volume":"332","author":"Bachmann","year":"2006","journal-title":"BMJ"},{"key":"key20150508101526144_ref1-bib104","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0895-4356(94)00098-B","article-title":"Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?","volume":"48","author":"Gr\u00e9goire","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"key20150508101526144_ref1-bib105","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/JCM.44.3.811-818.2006","article-title":"Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis","volume":"44","author":"Kr\u00fc\u00fcner","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key20150508101526144_ref1-bib106","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for The Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005","edition":"3rd edn."},{"key":"key20150508101526144_ref1-bib107","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jval.2012.06.011","article-title":"Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5","volume":"15","author":"Pitman","year":"2012","journal-title":"Value Health"},{"key":"key20150508101526144_ref1-bib108","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control","author":"","year":"2011"},{"key":"key20150508101526144_ref1-bib109","volume-title":"ERLN-TB Expert Opinion on the Use of the Rapid Molecular Assays for the Diagnosis of Tuberculosis and Detection of Drug Resistance","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib110","volume-title":"Position Statement: Direct Molecular Testing for Tuberculosis in England, Scotland and Wales","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib111","volume-title":"Methods for Development of NICE Public Health Guidelines.","author":"","year":"2012","edition":"3rd edn."},{"key":"key20150508101526144_ref1-bib112","volume-title":"National Audit of TB Diagnostic Laboratories and Description of Molecular Diagnostic Service Provision","author":"","year":"2012"},{"key":"key20150508101526144_ref1-bib113","volume-title":"Tuberculosis Enhanced Survey Data","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib114","volume-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis","author":"","year":"2011"},{"key":"key20150508101526144_ref1-bib115","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/thorax.55.11.962","article-title":"Resource implications of patients with multidrug resistant tuberculosis","volume":"55","author":"White","year":"2000","journal-title":"Thorax"},{"key":"key20150508101526144_ref1-bib116","first-page":"296","article-title":"Health status of UK patients with active tuberculosis","volume":"14","author":"Kruijshaar","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib117","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key20150508101526144_ref1-bib118","first-page":"1373","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis","volume":"9","author":"T\u00f6r\u00fcn","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20150508101526144_ref1-bib119","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1183\/09031936.00184312","article-title":"Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?","volume":"42","author":"Melchionda","year":"2013","journal-title":"Eur Respir J"},{"key":"key20150508101526144_ref1-bib120","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/GIM.0b013e318156dd07","article-title":"Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes","volume":"9","author":"Veenstra","year":"2007","journal-title":"Genet Med"},{"key":"key20150508101526144_ref1-bib121","volume-title":"Interim Life Tables 2008\u20132010","author":"","year":"2011"},{"key":"key20150508101526144_ref1-bib122","volume-title":"Health Survey for England","author":"","year":"2012"},{"key":"key20150508101526144_ref1-bib123","volume-title":"Guide to the Methods of Technology Appraisal","author":"","year":"2013"},{"key":"key20150508101526144_ref1-bib124","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1741-7015-11-190","article-title":"Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation","volume":"11","author":"Drobniewski","year":"2013","journal-title":"BMC Med"},{"key":"key20150508101526144_ref1-bib125","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon \u03b3release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2013","journal-title":"Thorax"},{"key":"key20150508101526144_ref1-bib126","volume-title":"NHS Reference Costs 2011\/12","author":"","year":"2012"},{"key":"key20150508101526144_ref1-bib127","volume-title":"National Tariff","author":"","year":"2012"},{"key":"key20150508101526144_ref1-bib128","volume-title":"British National Formulary.","author":"","year":"2013","edition":"66th edn."},{"key":"key20150508101526144_ref1-bib129","volume-title":"Unit Costs of Health and Social Care 2012","author":"Curtis","year":"2012"},{"key":"key20150508101526144_ref1-bib130","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.puhe.2012.11.010","article-title":"Factors affecting delay in initiation of treatment of tuberculosis in the Thames Valley, UK","volume":"127","author":"Saldana","year":"2013","journal-title":"Public Health"},{"key":"key20150508101526144_ref1-bib131","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00148365-200403020-00006","article-title":"Comparing utility scores before and after hearing-aid provision: results according to the EQ-5D, HUI3 and SF-6D","volume":"3","author":"Barton","year":"2004","journal-title":"Appl Health Econ Health Policy"},{"key":"key20150508101526144_ref1-bib132","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/01.AUD.0000134550.80305.04","article-title":"Criteria of candidacy for unilateral cochlear implantation in postlingually deafened adults II: cost-effectiveness analysis","volume":"25","author":"","year":"2004","journal-title":"Ear Hear"},{"issue":"41","key":"key20150508101526144_ref1-bib133","article-title":"The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model","volume":"13","author":"Bond","year":"2009","journal-title":"Health Technol Assess"},{"key":"key20150508101526144_ref1-bib134","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1007\/s11136-013-0417-6","article-title":"An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment","volume":"22","author":"Yang","year":"2013","journal-title":"Qual Life Res"},{"key":"key20150508101526144_ref1-bib135","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","article-title":"Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index","volume":"43","author":"Luo","year":"2005","journal-title":"Med Care"},{"key":"key20150508101526144_ref1-bib136","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","volume-title":"Infectious Diseases of Humans: Dynamics and Control","author":"Anderson","year":"1991"},{"key":"key20150508101526144_ref1-bib137","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1371\/journal.pmed.0030273","article-title":"Prospects for advancing tuberculosis control efforts through novel therapies","volume":"3","author":"Salomon","year":"2006","journal-title":"PLOS Med"},{"key":"key20150508101526144_ref1-bib138","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"key20150508101526144_ref1-bib139","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/S0140-6736(98)03199-7","article-title":"Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy","volume":"352","author":"Dye","year":"1998","journal-title":"Lancet"},{"key":"key20150508101526144_ref1-bib140","volume-title":"England and Wales Census","author":"","year":"2011"},{"key":"key20150508101526144_ref1-bib141","volume-title":"Tuberculosis In The UK: 2012 Report","author":"","year":"2012"},{"key":"key20150508101526144_ref1-bib142","volume-title":"Evaluation of the Find and Treat Service for the Control of Tuberculosis amongst Hard to Reach Groups","author":"Abubakar","year":"2011"},{"key":"key20150508101526144_ref1-bib143","first-page":"473","article-title":"Tuberculosis in a rural population of South India: a five-year epidemiological study","volume":"51","author":"","year":"1974","journal-title":"Bull World Health Organ"},{"key":"key20150508101526144_ref1-bib144","doi-asserted-by":"publisher","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20150508101526144_ref1-bib145","doi-asserted-by":"publisher","first-page":"e76533","DOI":"10.1371\/journal.pone.0076533","article-title":"Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis","volume":"8","author":"Arentz","year":"2013","journal-title":"PLOS ONE"},{"key":"key20150508101526144_ref1-bib146","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume":"309","author":"Thompson","year":"1994","journal-title":"BMJ"},{"key":"key20150508101526144_ref1-bib147","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1086\/597038","article-title":"Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis","volume":"48","author":"Davis","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19340\/hta19340.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19340\/hta19340.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:27:37Z","timestamp":1717885657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta19340\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":147,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2015,5]]}},"alternative-id":["10.3310\/hta19340"],"URL":"https:\/\/doi.org\/10.3310\/hta19340","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}